|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02252 MEDBOT-B
Nominal 
9.200 +0.480 (+5.505%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 99,237 | 108.468% | 47,603 | 1,048 | 0 | 0 |
| Cost of Sales | (52,224) | 104.519% | (25,535) | (357) | -- | -- |
| Gross Profit | 47,013 | 113.037% | 22,068 | 691 | -- | -- |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (26,140) | 1264.301% | (1,916) | 9,525 | (5,196) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (9,843) | -41.578% | (16,848) | (18,123) | (10,443) | 0 | |
| Profit / (Loss) before Taxation | (279,950) | -48.608% | (544,733) | (463,501) | (242,560) | (48,966) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,789 | -51.250% | 5,721 | 4,449 | 595 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (277,161) | -48.580% | (539,012) | (459,052) | (241,965) | (48,966) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,183 | 107.948% | 4,416 | (10,680) | (11,662) | 135 |
| Depreciation & Amortisation | 61,439 | 0.094% | 61,381 | 46,400 | 6,278 | 1,649 |
| Directors' Emoluments | -- | -- | -- | -- | 17,173 | 4,117 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | Unqualified | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -29.000 | -48.214% | -56.000 | -48.000 | -27.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.287 | -- | 0.994 | 2.078 | -- | -- |
| Remarks: | Real time quote last updated: 27/11/2024 16:11 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -277,161,000 |
| %Change | -48.580% |
| EPS / (LPS) | RMB -0.290 |
| NBV Per Share (¥) | RMB 0.287 |